2.39

1.65% -0.04

After Hours: 2.37 -0.02 -0.84%

Microbot Medical Inc (MBOT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Microbot Medical Inc stock is traded at $2.39, with a volume of 2.71M. It is down -1.65% in the last 24 hours and down -11.15% over the past month. Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

Previous Close:

$2.43

Open:

$2.47

24h Volume:

2.71M

Relative Volume:

1.36

Market Cap:

$160.51M

Revenue:

Net Income/Loss:

$-13.14M

P/E Ratio:

-7.8207

EPS:

-0.3056

Net Cash Flow:

$-13.11M

1W Performance:

+1.70%

1M Performance:

-11.15%

6M Performance:

-18.15%

1Y Performance:

-6.27%

1-Day Range:

$2.30

$2.53

1-Week Range:

$2.23

$2.69

52-Week Range:

$1.6001

$4.67

Microbot Medical Inc Stock (MBOT) Company Profile

Name

Microbot Medical Inc

Sector

Healthcare (1112)

Industry

Medical Instruments & Supplies (57)

Phone

908-938-5561

Address

25 RECREATION PARK DR SUITE 108, HINGHAM, MA

Employee

Twitter

@microbotmedical

Next Earnings Date

2026-03-24

Latest SEC Filings

MBOT's Discussions on Twitter

Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MBOT Microbot Medical Inc	2.39	163.19M	0	-13.14M	-13.11M	-0.3056
ISRG Intuitive Surgical Inc	468.36	165.94B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.52	44.30B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	80.73	38.96B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.93	38.69B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	228.80	33.61B	5.40B	1.49B	1.78B	10.12

Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-10-26	Initiated	B. Riley Securities	Buy
Dec-03-25	Initiated	Roth Capital	Buy
Jan-13-20	Reiterated	H.C. Wainwright	Buy
Dec-24-19	Reiterated	H.C. Wainwright	Buy
Jan-31-18	Initiated	Ladenburg Thalmann	Buy

Microbot Medical Inc Stock (MBOT) Latest News

05:25 AM

MBOT Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus

Apr 14, 2026

Microbot Medical to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - Bitget

Apr 14, 2026

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference - Yahoo Finance

Apr 14, 2026

Microbot Showcases LIBERTY Robotic System Full Release - TipRanks

Apr 14, 2026

Microbot to Spotlight LIBERTY Full Market Release, CEO to Present at Needham Conference - TradingView — Track All Markets

Apr 14, 2026

Microbot Medical (NASDAQ: MBOT) to spotlight LIBERTY robotic system FMR - Stock Titan

Apr 14, 2026

H.C. Wainwright Maintains Microbot Medical(MBOT.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Apr 14, 2026

H.C. Wainwright reiterates Microbot Medical stock rating on full market release - Investing.com

Apr 14, 2026

Apr 13, 2026

Emory Healthcare IRs 1st in the world to use newly approved robotic system for liver, prostate procedures - Radiology Business

Apr 13, 2026

Bear Alert: Is Microbot Medical Inc stock a value trap2026 Final Week & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Microbot Medical (MBOT) Expands LIBERTY Robot System Release in U.S. - GuruFocus

Apr 13, 2026

Microbot Medical launches full market release of robotic system By Investing.com - Investing.com South Africa

Apr 13, 2026

Microbot Medical Launches Full Market Release of FDA-Cleared LIBERTY Endovascular Robotic System in the U.S - Minichart

Apr 13, 2026

Microbot Medical launches full market release of robotic system - Investing.com

Apr 13, 2026

Microbot Medical launches full U.S. LIBERTY system rollout - TipRanks

Apr 13, 2026

Microbot Medical begins U.S. full market release of LIBERTY after successful limited release - TradingView — Track All Markets

Apr 13, 2026

LIBERTY robot rollout widens for Microbot Medical (NASDAQ: MBOT) - Stock Titan

Apr 13, 2026

Only FDA-cleared single-use endovascular robot expands U.S. rollout - Stock Titan

Apr 13, 2026

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - Sahm

Apr 13, 2026

Microbot Medical Commences Full Market Release (FMR) of the LIBERTY Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - Moomoo

Apr 13, 2026

Apr 10, 2026

Microbot Medical Inc. Files Form 8-K – Company Details, NASDAQ Listing, and Contact Information (April 10, 2026) - Minichart

Apr 10, 2026

Microbot Medical Expands At-The-Market Equity Offering Program - TipRanks

Apr 10, 2026

Form 424B5 Microbot Medical Inc. - StreetInsider

Apr 10, 2026

Microbot Medical (MBOT) files ATM to raise up to $39.2M for LIBERTY® development - Stock Titan

Apr 10, 2026

Microbot Medical prices ATM program up to $39.2M, files prospectus supplement - TradingView — Track All Markets

Apr 10, 2026

Microbot Medical (NASDAQ: MBOT) outlines $39,230,691 at-the-market stock plan - Stock Titan

Apr 10, 2026